Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares PRKAR1A, Endocrine-related cancer, Exelixis, Rare cancers of childhood (NCI PDQ umbrella) and the tag endocrine.
Shares Multiple endocrine neoplasia syndromes (MEN1, MEN2, MEN4), Rare cancers of childhood (NCI PDQ umbrella), RET, Cabozantinib and the tag endocrine.
Shares Medullary thyroid cancer, RET, Radioligand therapy (beta emitters), Germline (hereditary) testing and the tag endocrine.
Shares Cabozantinib, VEGF / VEGFR, Radioligand therapy (beta emitters), Germline (hereditary) testing and the tag endocrine.
Shares Cabozantinib, VEGF / VEGFR, PD-1, Pembrolizumab and the tag endocrine.
Shares Cabozantinib, VEGF / VEGFR, Radioligand therapy (beta emitters), Germline (hereditary) testing and the tag endocrine.
Shares Tumour differentiation (well / moderately / poorly differentiated), Radioligand therapy (beta emitters) and the tag endocrine.
The same record for scripts and assistants; checked 2026-09-04. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.